MT200605
/ Shaanxi Micot Technology
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
October 04, 2025
A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
(clinicaltrials.gov)
- P2 | N=360 | Recruiting | Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd.
New P2 trial • Cardiovascular • Ischemic stroke
November 21, 2024
A SAD/MAD Study to Evaluate the Safety, Tolerability, PK of MT200605 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=61 | Completed | Sponsor: Shaanxi Micot Technology Limited Company | Enrolling by invitation ➔ Completed | Trial completion date: Sep 2024 ➔ Feb 2024 | Trial primary completion date: Jul 2024 ➔ Jan 2024
Trial completion • Trial completion date • Trial primary completion date
July 17, 2023
A SAD/MAD Study to Evaluate the Safety, Tolerability, PK of MT200605 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=60 | Enrolling by invitation | Sponsor: Shaanxi Micot Technology Limited Company
New P1 trial
1 to 3
Of
3
Go to page
1